Innovators with breakthrough products face an increasingly competitive and price sensitive environment. To secure stakeholder support, an early focus on strategic value is paramount.
Please join CRA for a complimentary dinner seminar at J.P. Morgan focused on how to drive success for breakthrough therapies by aligning strategy with innovation. We will discuss strategies for:
- Identifying high value patient groups,
- Targeting for clinical trial enrollment, and
- Focusing product development to deliver value that resonates across payer, patient, and physician stakeholder groups.
The areas where this is of particular relevance range from potentially curative gene therapies (especially for later entrants) to well established markets such as autoimmune and inflammatory diseases where novel agents seek to demonstrate unique benefit to underserved niches.
Cocktails: 6:00 pmDinner and Discussion: 7:00 pm
To RSVP for this event, click here.